
|Videos|May 5, 2021
Clinical results analyze dexamethasone implant effect on macular thickness
Author(s)David Hutton, OTE Staff Reports
Dr. Daniel F. Kiernan discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.
Advertisement
Dr. Daniel F. Kiernan, a vitreoretinal surgeon at The Eye Associates, Sarasota, Florida, discusses the highlights of his 2021 ARVO virtual presentation on the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on optical coherence tomography (OCT) testing following vitreoretinal surgery.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: BRUNELLO 1-year results for remigromig in DME
2
AAO 2026: MCO-010 sustains vision gains in RP through 4 years
3
Clobetasol cuts post-cataract inflammation and pain in phase 3 trial
4
AAO 2026: Tinlarebant in Stargardt disease: Jacque Duncan, MD, on DRAGON results
5


















